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Modifiable Predictors of Ventricular Ectopy in the Community
Tuomas Kerola, MD; Thomas A. Dewland, MD; Eric Vittinghoff, PHD, MPH; Susan R. Heckbert, MD, PHD; Phyllis K. Stein, PHD;
Gregory M. Marcus, MD, MAS
Background-—Premature ventricular contractions (PVCs) predict heart failure and death. Data regarding modifiable risk factors for
PVCs are scarce.
Methods and Results-—We studied 1424 Cardiovascular Health Study participants randomly assigned to 24-hour Holter
monitoring. Demographics, comorbidities, habits, and echocardiographic measurements were examined as predictors of PVC
frequency and, among 845 participants, change in PVC frequency 5 years later. Participants exhibited a median of 0.6
(interquartile range, 0.1–7.1) PVCs per hour. Of the more directly modifiable characteristics and after multivariable adjustment,
every SD increase in systolic blood pressure was associated with 9% more PVCs (95% confidence interval [CI], 2%–17%; P=0.01),
regularly performing no or low-intensity exercise compared with more physical activity was associated with 15% more PVCs (95%
CI, 3–25%; P=0.02), and those with a history of smoking exhibited an average of 18% more PVCs (95% CI, 3–36%; P=0.02) than did
never smokers. After 5 years, PVC frequency increased from a median of 0.5 (IQR, 0.1–4.7) to 1.2 (IQR, 0.1–13.8) per hour
(P<0.0001). Directly modifiable predictors of 5-year increase in PVCs, described as the odds per each quintile increase in PVCs,
included increased diastolic blood pressure (odds ratio per SD increase, 1.16; 95% CI, 1.02–1.31; P=0.02) and a history of smoking
(OR, 1.31; 95% CI, 1.02–1.68; P=0.04).
Conclusions-—Enhancing physical activity, smoking cessation, and aggressive control of blood pressure may represent fruitful
strategies to mitigate PVC frequency and PVC-associated adverse outcomes. ( J Am Heart Assoc. 2018;7:e010078. DOI: 10.
1161/JAHA.118.010078.)
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P remature ventricular contractions (PVCs) are associatedwith a worse prognosis among individuals with a variety
of cardiac conditions.1,2 Building on evidence that successful
catheter ablation of PVCs can normalize reduced systolic
function among patients with a high burden of ventricular
ectopy,3 our group demonstrated that community-dwelling
individuals with more PVCs exhibited a higher risk of incident
systolic dysfunction, heart failure, and death.4,5 More
recently, we reported that a PVC from a single 12-lead ECG
predicted incident heart failure both before and after adjusting
for known heart failure risk factors in 2 different community-
based populations.6
The cause of PVCs, and particularly varying frequencies of
PVCs, remains largely unknown. Identifying modifiable behav-
iors or exposures that might influence the burden of
ventricular ectopy may be useful. We therefore sought to
leverage data collected from participants in the CHS (Cardio-
vascular Health Study) to identify predictors of PVC fre-
quency.
Methods
The authors will make the methods (codes for the statistical
analysis) available to any researcher for purposes of repro-
ducing the results. The data belong to the CHS, and the
authors therefore do not have the authority to share the study
data with investigators outside the University of California,
San Francisco; however, investigators can submit an applica-
tion to obtain the data directly from the CHS using their
established processes.
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Study Design
The CHS is a prospective, community-based cohort study
sponsored by the National Heart, Lung, and Blood Institute.
Details regarding eligibility, enrollment, and follow-up have been
previously published.7–9 Briefly, 5201 subjects 65 years of age
or older were recruited between 1989 and 1990 from a random
sample of Medicare beneficiaries by 4 academic centers (Johns
Hopkins University, Wake Forest University, University of
Pittsburgh, and University of California, Davis). An additional
687 black patients were recruited between 1992 and 1993. All
participants underwent a medical history, physical examination,
laboratory testing, and 12-lead electrocardiography at enroll-
ment. Participants were then followed with annual clinic visits
and semiannual telephone contact for 10 years, with telephone
contact continued every 6 months thereafter. Participants
provided written informed consent, and the study protocol
was approved by the institutional review board of each center.
Study Population
Our analysis was restricted to the subset of 1424 participants
randomly assigned to 24-hour ambulatory ECG (Holter)
monitoring during their initial assessment and who were part
of the initial recruitment cohort (those recruited between
1989 and 1990). Of these, 845 participants underwent a
second 24-hour ambulatory Holter 5 years later.
Holter Assessment
Holter data were analyzed at the Washington University
School of Medicine Heart Rate Variability Laboratory using a
MARS 8000 Holter scanner (GE Medical Systems, Milwaukee,
WI), and all PVCs were identified. The results were then
manually reviewed to ensure accuracy. The PVC frequency
was characterized as PVCs per hour, defined as the total
number of PVCs divided by the duration of the Holter
recording.
Covariate Ascertainment
Demographics and anthropometric measurements
Self-identified race was categorized as white, black, Asian/
Pacific Islander, and other. Due to the small number of
nonwhite participants, race was dichotomized as white versus
nonwhite for the regression analyses. Self-identified sex was
classified as male or female. Level of education was
determined according to self-reported number of educational
years. Anthropometric measurements included weight, height,
and waist and hip circumferences. Blood pressure and heart
rate were measured in the right arm of seated participants
after a 5-minute rest period using an appropriately sized cuff,
and the average of 2 measurements was used for analysis.
Cardiovascular comorbidities
Hypertension was defined as either a reported history of
physician-diagnosed hypertension combined with the use of
antihypertensive medications or a baseline study visit systolic
blood pressure ≥140 mm Hg or diastolic pressure
≥90 mm Hg. Diabetes mellitus was defined as use of an
antihyperglycemic medication at baseline or a fasting glucose
level ≥126 mg/dL. Congestive heart failure and myocardial
infarction (MI) were identified by participant self-report and
confirmed by medical record verification.9 Coronary heart
disease was defined as angina, previous MI, previous coronary
artery bypass graft surgery, or previous angioplasty identified
by participant self-report and confirmed by medical record
verification.9 Atrial fibrillation was defined as a reported
history of atrial fibrillation at the first study encounter, on
baseline 12-lead ECG, or on baseline Holter monitoring.
Physical activity
Usual leisure-time activity was assessed using a modified,
validated Minnesota Leisure-Time activity questionnaire.10
The questionnaire evaluated frequency and duration of 15
different activities during the preceding 2 weeks, including
gardening, mowing, raking, swimming, hiking, aerobics, ten-
nis, jogging, racquetball, walking, golfing, bicycling, dancing,
calisthenics, and exercise cycling. Each activity was defined
as having an intensity value in metabolic equivalent task units,
and participant responses regarding types, frequency, and
duration of each activity were used to calculate weekly energy
expenditure (kcal/week) from leisure-time activity. Usual
exercise intensity was also separately assessed: based on the
Clinical Perspective
What Is New?
• In a community-based cohort, readily modifiable predictors
of more frequent ventricular ectopy included a higher
systolic blood pressure, less regular physical activity, and
smoking.
• Over 5 years of follow-up, those with an increased diastolic
blood pressure and history of smoking exhibited signifi-
cantly larger increases in premature ventricular contraction
counts.
What Are the Clinical Implications?
• Optimizing blood pressure control, enhancing regular phys-
ical activity, and abstinence from smoking may all help
reduce premature ventricular contraction frequency and
consequently premature ventricular contraction–associated
adverse outcomes.
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highest-intensity leisure-time activity reported over the pre-
ceding 2 weeks, participants were categorized as having
engaged in high, moderate, or low-intensity activity or none,
where high-intensity activity was estimated to require >6
metabolic equivalent tasks.10 To ascertain the association of
at least moderately intensive exercise with PVC frequency,
exercise intensity was dichotomized into no and low-intensity
exercisers versus moderate- and high-intensity exercisers for
regression analyses.
Medications
Baseline angiotensin-converting enzyme inhibitor, b-blocker,
and calcium channel blocker use were ascertained using an
in-home medication inventory. Use of a particular medicine
required a current prescription filled by a pharmacist or
physician that was taken by the patient in the previous
2 weeks.11
Habits
Self-reported usual consumption of the number of alcoholic
drinks (1 drink was defined as a 12-ounce can or bottle of
beer, a 6-ounce glass of wine, or a shot of liquor) was used to
estimate weekly alcohol consumption. Smoking status was
dichotomized as ever (current and former) versus never and
was quantified as the average daily consumption of cigarettes
when smoking, the length of smoking history in years, and
average packs of cigarettes per day based on self-report.
Smoking pack-years were calculated by multiplying the
average packs of cigarettes per day by the duration of
smoking in years.8
Echocardiography
The echocardiographic assessment of participants in the CHS
has been previously described.12 In brief, 2-dimensional
echocardiography, 2-dimensional targeted M-mode, and Dop-
pler imaging were performed on each participant at baseline
using Toshiba SSH-160A echocardiography machines
(Toshiba Medical Systems, Tustin, CA) equipped with 2.5-
and 3.75-MHz transducers. Imaging was performed at the
highest Mhz that provided adequate tissue penetration for 2-
dimensional imaging. Images were recorded and stored on
Super-VHS videotape at the recruitment sites and then
transferred to the University of California, Irvine, for central
interpretation.12 In all participants, left ventricular (LV)
function was qualitatively assessed from the 2-dimensional
imaging views, where at least 80% of the myocardium was
visualized. Function was categorized qualitatively as normal,
borderline, or abnormal, with 94% interreader agreement and
98% intrareader agreement of paired studies.12 Because of
the small number of participants with ejection fraction
classified as “abnormal,” qualitative ejection fraction was
dichotomized for regression analyses into (1) borderline or
abnormal versus (2) normal. In a subpopulation of 952
individuals, LV mass and fractional shortening were derived
from M-mode measurements, using leading-edge-to-leading-
edge methodologies per American Society of Echocardiogra-
phy standards.13 LV mass was calculated using the Devereux
formula and indexed by dividing it by the body surface area.14
Statistical Analysis
Continuous variables with a normal distribution are presented
as meanSD and were compared using Student t tests. Non–
normally distributed continuous variables are presented as
medians with interquartile ranges and were compared using
the Mann-Whitney U-test. Categorical variables are presented
as numbers and percentages and were compared using the
chi-square test.
Linear regression was used to estimate the associations of
covariates with baseline PVC frequency, which was log base 2
transformed to meet normality assumptions. Most continuous
covariates were expressed in units of standard deviation, and
their regression coefficients (bs) were back-transformed using
the standard formula 1009[exp(b9ln(2))1] to obtain esti-
mates of the percentage difference in PVC frequency for each
SD increment in a normally distributed continuous predictor,
or given the presence (versus absence) of a categorical
predictor. To meet the assumption of model linearity kcal of
activity, pack-years of cigarette smoking, and cigarettes per
day were log base 2 transformed, which led to improved
model fit. Back transformation using the same formula yielded
the percentage increase in PVC frequency for each doubling
of the predictor. Log base 2 transformation was chosen to
remain consistent with the previous literature on the
subject.4,15 Because changes in PVC frequency between the
baseline and follow-up Holter studies exhibited a long tail,
they were divided into quintiles and analyzed using propor-
tional odds models. Of the 3 highly collinear smoking
variables, smoking status (as defined above) was selected
as the primary covariate to represent smoking history;
additional analyses substituting current smokers, ex-smokers,
overall smoke pack-years, and cigarettes per day were also
performed.
In the cardiac electrophysiology literature, a high-burden of
PVCs is considered relevant to cardiomyopathy risk (such as
in determining optimal ablation candidates)3,16,17; we there-
fore performed additional analyses dichotomizing participants
with more versus less than 5% and 10% PVCs. Although >20%
or >10% PVCs are commonly used as thresholds for this
purpose, no one exhibited more than 18% PVCs.3,16,17
Because b-blockers are often empirically used to relieve
symptoms related to PVCs, we performed secondary analyses
comparing PVC frequency assessed from the baseline and 5-
year Holter studies to the status of b-blocker use at each time
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Table 1. Baseline Characteristics of Participants Exhibiting Below and Above the Median Number of PVCs per Hour (median=0.6)
Characteristic ≤Median PVCs/Hour (n=713) >Median PVCs/Hour (n=711) P Value
Age, y 71.54.8 72.45.1 0.001
Sex, male, % 270 (37.9) 392 (55.1) <0.0001
Race,
White, % 680 (95.4) 673 (94.7) 0.71
Black, % 28 (3.9) 35 (4.9)
American Indian/Alaskan, % 2 (0.3) 1 (0.1)
Asian/Pacific Islander, % 1 (0.1) 1 (0.1)
Other, % 2 (0.3) 2 (0.3)
Educational level, y 14.24.5 144.5 0.40
Height, cm 166.39.0 169.89.8 <0.0001
Weight, kg 71.113.0 74.313.2 <0.0001
Body mass index, kg/m² 26.64.3 26.74.0 0.60
Waist-to-hip ratio 0.910.10 0.930.09 0.001
Systolic blood pressure, mm Hg 133.620.4 135.421.3 0.11
Diastolic blood pressure, mm Hg 69.711.0 70.311.3 0.35
Heart rate, beats per minute 63.910.6 63.911.1 1.00
Hypertension, % 376 (52.8) 405 (57.0) 0.11
Diabetes mellitus, % 101 (14.2) 115 (16.3) 0.27
Coronary heart disease, % 124 (17.4) 161 (22.6) 0.01
Congestive heart failure, % 17 (2.4) 31 (4.4) 0.04
Myocardial infarction, % 56 (7.9) 102 (14.3) 0.01
Atrial fibrillation, % 13 (1.8) 19 (2.7) 0.28
Leisure-time physical activity, kcal/week (IQR) 1369 (557–2863) 1182 (478–1182) 0.03
Exercise intensity
No exercise, % 32(4.5) 51 (7.2) 0.09
Low, % 327 (45.9) 342 (48.1)
Intermediate, % 272 (38.2) 244 (34.3)
High, % 81 (11.4) 74 (10.4)
ACE inhibitors, % 35 (4.9) 52 (7.3) 0.06
b-Blockers, % 98 (13.7) 108 (15.2) 0.43
Calcium channel blockers, % 78 (10.9) 77 (10.8) 0.95
Alcohol consumption, units/week 2.35.6 2.66.0 0.22
Smoking status
Never, % 359 (50.4) 291 (41.0) 0.002
Ex-smoker, % 289 (40.5) 349 (49.2)
Current smoker, % 65 (9.1) 70 (9.9)
Smoke pack-years (IQR) 0 (0–24.0) 6.6 (0–38.0) <0.0001
Cigarettes per day (IQR) 0 (0–15) 8 (0–20) <0.0001
Left ventricular ejection fraction
Normal, % 670 (94.4) 617 (88) <0.0001
Borderline, % 32 (4.5) 47 (6.7)
Abnormal, % 8 (1.1) 37 (5.3)
Left ventricular mass index, g/m2* 81.120.5 89.421.4 <0.0001
Left ventricular fractional shortening, %* 42.97.5 40.48.6 <0.0001
Data are presented as meansSD, medians (interquartile range [IQR]) or numbers (percentage). ACE indicates angiotensin-converting enzyme; and PVC, premature ventricular contraction.
*Available for 954 participants.
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point; these analyses were repeated after adjusting for age
and sex.
Multivariate models included sex and age, as well as
covariates associated with the outcome at P<0.10 in unad-
justed analysis and then retained by backwards selection with
a retention criterion of P<0.10. Multivariable-adjusted predic-
tors were categorized as immutable (eg, age and height),
potentially modifiable (eg, ejection fraction), and directly
modifiable (such as conditions that could be modified with
available medicines or habits that could, at least theoretically,
change). Baseline PVC frequency was significantly associated
with categorized change in PVC frequency and thus included
as a covariate in the proportional odds models for this
outcome, after log base 2 transformation to meet linearity
assumptions.
Data were analyzed using SPSS Statistics for Windows,
version 23 (IBM Corp, Armonk, NY). A 2-tailed P<0.05 was
considered statistically significant.
Results
The mean length of the Holter recording was 21.82.5 hours,
yielding a median hourly frequency of PVCs of 0.6 (interquartile
range, 0.1–7.1). A total of 261 (18.3%) participants had no
PVCs. The baseline characteristics of the participants are
shown in Table 1. Those exhibiting above the median PVC
frequency were older, were more oftenmale, had greater height
and weight, had more cardiovascular disease, engaged in less
physical activity, and had a history of smoking. Unadjusted
predictors of PVC frequency are included in Table 2. After
multivariable adjustment, those who were older, taller, and with
a lower ejection fraction had more PVCs. Of the modifiable
predictors, systolic blood pressure, performing less than
moderate-intensity physical activity and having ever (versus
never) smokedwere each independently associated with higher
PVC frequency (Figure 1). While current smokers (n=135)
exhibited 20% more PVCs, this relationship did not achieve
statistical significance (95% confidence interval, 5% to 55%;
P=0.12); in contrast, among the more numerous ex-smokers
(n=638), statistical significance was reached (18% more PVCs;
95% confidence interval, 2–36%; P=0.03). No interactions with
sex were observed.
Eleven participants exhibited a PVC burden >10%, and no
statistically significant predictors of this PVC frequency were
observed. Both older age (SD adjusted odds ratio, 1.43; 95%
confidence interval, 1.09 to1.90; P=0.001) and lower exercise
intensity (odds ratio for those with greater exercise intensity,
0.31; 95% confidence interval: 0.14–0.68, P=0.004) were
associated with a PVC burden >5% (observed in 38 partici-
pants).
In the subset with available fractional shortening and LV
mass index measurements (n=952) older age, being taller,
Table 2. Unadjusted Relationships Between Baseline
Covariates and PVC Frequency
Characteristic, Unit (SD)
Percent Increase
(95% CI)* P Value
Immutable
Age, y (4.9) 16 (9 to 24) <0.0001
Male 74 (52 to 99) <0.0001
White race (vs nonwhite) 19 (41 to 10) 0.18
Height, cm (9.4) 33 (24 to 42) <0.0001
Potentially modifiable
Educational level, y (4.5) 4 (11 to 2) 0.19
Weight, kg (13.3) 22 (15 to 31) <0.0001
Body mass index, kg/m² (4.2) 4 (3 to 12) 0.25
Waist-to-hip ratio (0.10) 19 (10 to 28) <0.0001
Heart rate, beats
per minute (10.9)
0 (6 to 7) 0.92
Hypertension 14 (1 to 31) 0.06
Diabetes mellitus 11 (9 to 34) 0.30
Coronary heart disease 29 (9 to 53) 0.003
Congestive heart failure 87 (28 to 172) 0.001
Myocardial infarction 64 (32 to 104) <0.0001
Atrial fibrillation 36 (14 to 115) 0.19
Ejection fraction below normal† 109 (65 to 165) <0.0001
Left ventricular
mass index, g/m² (20.9)‡
28 (19 to 37) <0.0001
Left ventricular
fractional shortening, % (8.0)§
22 (28 to 16) <0.0001
Directly modifiable
Systolic blood
pressure, mm Hg (21.5)
10 (2 to 18) 0.01
Diastolic blood
pressure, mm Hg (11.2)
6 (1 to 14) 0.09
Leisure-time physical activity§ 2 (4 to 1) 0.007
Exercise intensityk 17 (27 to 5) 0.009
ACE inhibitors 37 (3 to 82) 0.03
b-Blockers 18 (3 to 43) 0.096
Calcium channel blockers 2 (21 to 22) 0.87
Alcohol consumption,
units/week (10.8)
3 (10 to 17) 0.70
Smoking status¶ 31 (15 to 51) <0.0001
ACE indicates angiotensin-converting enzyme; CI, confidence interval; PVC, premature
ventricular contractions.
*Percent increase in premature ventricular contractions PVC per hour per SD in
continuous covariate/presence vs absence of dichotomous covariate.
†Dichotomized into abnormal and borderline ejection fraction vs normal ejection fraction.
‡Available for 952 participants.
§Percent increase in PVCs per every doubling of leisure-time physical activity.
kDichotomized into high and intermediate intensity exercisers vs low intensity and no
exercisers.
¶Dichotomized into ever smokers vs never smokers.
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decreased fractional shortening, and increased LV mass index
were each statistically significantly associated with a higher
PVC frequency after multivariable adjustment (Figure 1).
Smoking remained statistically significantly associated with
more PVCs whether analyzed as any history of smoking (versus
none; Figure 1) or, as shown in Table 3, analyzed as total
smoking pack-years or number of cigarettes smoked per day.
The median baseline PVC frequency among the participants
with 2 Holter recordings was 0.5 (0.1–4.7) per hour, increasing
to a median 1.2 (0.1–13.8) in the follow-up Holter 5 years later
(P<0.0001). The unadjusted predictors of the change in PVC
frequency are shown in Table 4. Similar to the predictors of
increased PVCs in the cross-sectional analyses, in unadjusted
analyses, male sex, greater height and weight, prevalent
cardiovascular disease, and history of ever smoking were all
significantly associatedwithagreater increase inPVC frequency
over time. In the multivariable analyses, potentially modifiable
predictors of increasing PVCs included a history of MI and a
reduced ejection fraction, whereas directly modifiable predic-
tors of an increase in 5-year PVC frequency included increased
diastolic blood pressure and a history of smoking (Figure 2). In
the subset of participants with fractional shortening and LV
mass index measurements available, lower fractional shorten-
ing, a history of MI, and a history of smoking were each
significantly associated with increasing PVC frequency.
When smoking was analyzed as a continuous variable, both
greater pack-years and number of cigarettes smoked per day
were associated with a greater change in PVC frequency, but
statistical significance was reached only in certain multivari-
ate models (Table 3).
We were unable to detect any statistically significant
changes in PVC frequency with changing b-blocker use
between the baseline and 5-year Holters (Table S1).
Discussion
In this community-based cohort, a higher blood pressure, less
physical activity, and smoking were each associated with
more baseline PVCs after adjusting for relevant confounders
and mediators. While different aspects of a higher blood
pressure predicted both baseline PVCs (systolic blood pres-
sure) and an increase in PVCs over time (diastolic blood
pressure), smoking demonstrated the most consistent rela-
tionship with PVC frequency across several analyses.
Total population (n=1424)  Percent increase* p
Characteristic, unit (SD) ←fewer PVCs more PVCs →
Age, years (4.9) 11 0.003
Male 11 0.32
Height, cm (9.4) 23 <0.0001
Systolic blood pressure, mmHg (21.5) 9 0.01
Congestive heart failure 45 0.051
Myocardial infarction 22 0.07
Exercise Intensity† -15 0.02
Smoking status‡ 18 0.02
Ejection fraction§ 59 <0.0001
Subpopulation with LV measurements (n=952) Percent increase* p
Age, years (4.9) 13 0.004
Male -2 0.78
Height, cm (9.4) 16 0.01
Smoking status‡ 18 0.08
Ejection fraction§ 33 0.08
Left ventricular (LV) mass index, g/m² (20.9) 16 <0.0001
LV fractional shortening, % (8.0) -15 <0.0001
(-2 to 53)
(-5 to 85)
(9 to 25)
(-25 to -3)
(3 to 36)
(0 to 39)
(4 to 23)
(3 to 31)
(-5 to 85)
(95% CI)
(3 to 19)
(-9 to 36)
(0 to 111)
(95% CI)
(-24 to 26)
(-22 to -8)
(12 to 36)
(2 to 17)
-40 -20 0 20 40 60 80 100 120
Figure 1. Multivariable adjusted predictors of premature ventricular contraction (PVC) frequency. Multivariable models including all covariates
listed for each population (please see the Methods section for selection of covariates). *Percent increase in PVCs per hour per SD of continuous
covariate or the presence (vs absence) of each categorical variable. †Dichotomized into high- and intermediate-intensity exercisers vs low-
intensity and no exercisers. ‡Dichotomized into ever smokers vs never smokers. §Dichotomized into abnormal and borderline ejection fraction
vs normal ejection fraction.
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Smoking predicted both more PVCs at baseline and a
significant increase in PVCs over time, whether analyzed as
any history of smoking, number of pack-years, or number of
cigarettes smoked per day. In the subset with all LV
echocardiographic measurements available, an increase in
LV mass index and a reduction in systolic function (as
reflected by fractional shortening) were also found to be
important predictors of more PVCs.
To our knowledge, this is the first community-based
assessment of predictors of PVC frequency accompanied by
echocardiography data as well as the first such study to
evaluate predictors of changes in PVC frequencies over time.
Previous literature has reported conflicting results regarding
the relationship between cardiovascular risks factors and PVC
frequency. An analysis of the ARIC (Atherosclerosis Risks in
Community) study (including community-dwelling individuals
enrolled at 45–65 years of age) found that male sex, black
race, lower educational attainment, higher heart rate, pres-
ence of any heart disease, hypertension, and hypomagne-
semia were each associated with at least 1 PVC during a
2-minute ECG recoding. The PVCs were not quantified and,
unlike in the current analysis, alcohol consumption, a history
of smoking, and echocardiographic measures were not
included.18 More recently, a study of 2048 young, healthy
adults from the Principality of Liechtenstein found that,
consistent with our current report, those with more PVCs
were taller and generally performed less strenuous exercise.19
While no statistically significant relationships between general
smoking status and PVCs were observed, those who had a
history of at least 15 pack-years of smoking did exhibit
significantly more PVCs in one of their multivariable adjusted
models. Neither systolic nor diastolic blood pressures were
associated with PVC frequency in the Liechtenstein study.
Although this study did not include some potentially important
covariates, such as alcohol use or echocardiographic mea-
surements or changes in PVC frequency over time, the
disparate results with our current study may be attributable to
the younger population in the Liechtenstein study. Specif-
ically, perhaps smoking and a higher blood pressure require
more time or perhaps involve other interactions with age,
becoming manifest risk factors of PVC frequency only in older
individuals.
Our most robust and consistent observation was that
smoking was associated with more PVCs. There are several
potential mechanisms that may underlie this relationship.
First, smoking has known causal relationships with several of
the phenomena identified in our study as risk factors for
increased PVC frequency, including a higher blood pressure, a
reduced ejection fraction and, in regards to increasing PVC
frequency over time, MI.20 Interestingly, however, smoking
remained an important predictor of increased PVCs even after
adjusting for those covariates, suggesting there may be a
more direct proarrhythmic effect. In addition to enhancing the
risk for those chronic cardiovascular diseases, smoking is
known to acutely increase sympathetic tone, which might
have an immediate effect on cardiac ectopy.21 Indeed, in an
ambulatory Holter study among 31 smokers, both premature
atrial contractions and PVCs were more commonly observed
during the same hours that participants reported smoking.22
Nicotine, which itself may mediate sympathetic effects,23 has
also been shown to enhance myocardial fibrosis,24 potentially
contributing to a substrate more prone to automaticity25 or
micro-reentry.26 Separately, carbon monoxide–induced hypoxia
at the cellular level of the myocardium and oxidative stress
produced by smoking are other possible direct mechanisms
working either alone or in concert with the other described
mechanisms predisposing smokers to arrhythmias.23
Higher blood pressure was the other directly modifiable
characteristic associated with both baseline PVC frequency
and an increase in PVCs over time. Although restricted to a
smaller population in our study, the statistical significance of
those relationships was lost after including LV shortening and
Table 3. Relationship Between Continuous Measures of
Smoking and PVC Frequency
PVC Frequency
Percent Increase* (95% CI) P Value
Smoke pack-years
Model 1 1 (0–2) 0.009
Model 2 1 (0–2) 0.03
Number of cigarettes smoked/day
Model 1 1 (0–2) 0.01
Model 2 1 (0–3) 0.04
5-Year Change in PVC Frequency
Odds Ratio† (95% CI) P Value
Smoke pack-years
Model 3 1.06 (0.99–1.14) 0.07
Model 4 1.08 (1.00–1.18) 0.04
Number of cigarettes smoked/day
Model 3 1.07 (1.00–1.14) 0.047
Model 4 1.08 (1.00–1.07) 0.05
Model 1: Adjusted for age, sex, height, systolic blood pressure (BP), congestive heart
failure, myocardial infarction, exercise intensity, left ventricular ejection fraction (EF);
Model 2: Adjusted for age, sex, height, EF, left ventricular mass index, fractional
shortening, Model 3: Adjusted for age, sex, height, diastolic BP, history of myocardial
infarction, EF; Model 4: Adjusted for age, sex, height, history of myocardial infarction, EF,
left ventricular mass index and fractional shortening. CI indicates confidence interval;
and PVC, premature ventricular contractions.
*Percent increase in PVCs per hour for each doubling of pack-years or cigarettes
smoked per day.
†The odds ratio for a one-quintile increase in 5-year change in PVCs per hour between
baseline and 5-year Holters, for each doubling of pack-years or cigarette smoked per
day.
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LV mass into the multivariable model, suggesting that such
functional and structural LV changes might mediate this
association. While only systolic blood pressure remained
statistically significantly associated with baseline PVC fre-
quency and diastolic blood pressure remained similarly
associated with an increase in PVC frequency over time after
multivariable adjustment, these findings are consistent with
both the ARIC study mentioned above18 and a previous case-
control analysis wherein 50 hypertensive individuals exhibited
more PVCs than did controls.27
A reduced LV ejection fraction was another consistent
predictor of both more baseline PVCs and an increase in PVCs
over 5 years. In our earlier study among the present cohort,
we found individuals in the upper quartile (with more 100
PVCs/day) after adjustment to relevant confounders to have
48% higher risk of incident congestive heart failure during the
follow-up when compared with those in the lowest quartile.4
While some of this relationship might be explained by “reverse
causation,” where the PVCs might actually contribute to a
reduced ejection fraction,28 the 5-year increase in PVCs
among participants with a lower LV ejection fraction suggests
that a bidirectional relationship may be possible. A history of
MI also predicted a 5-year increase in PVCs, demonstrating
that structural heart disease in the ventricle is likely
important. Again, fibrosis may play a role in these
patients,29,30 providing a substrate for insulated cardiomy-
ocytes that may lose their normal electronic interactions with
surrounding tissue and therefore depolarize and propagate to
become a PVC31 or provide an area of heterogeneous
conduction and repolarization to facilitate reentry.26
In the cardiac electrophysiology literature, particularly high
burdens of PVCs are often used to identify optimal candidates
for ablation among patients with an established cardiomy-
opathy.3,15,16 The number of participants with burdens in
those ranges was relatively small in our current community-
based study, although both older age and less exercise
intensity were more common in those with at least 5% PVCs.
It is important to emphasize, however, that we previously
demonstrated both statistically significant and clinically
meaningful enhanced risks of incident heart failure, reduc-
tions in LV ejection fraction, and death associated with
relatively small increases in PVCs using this same cohort.4
While less cumulative leisure-time physical activity was
associated with higher PVC frequency only in an unadjusted
model, less regular exercise intensity exhibited statistically
significant relationships with increased baseline PVC fre-
quency both before and after multivariable adjustment. More
physical activity may reduce PVCs through a variety of
Total population (n=845) Odds ratio* p
Characteristic, unit (SD) ←fewer PVCs            more PVCs →
Age, years (4.9) 1.11 0.11
Male 1.11 0.59
Height, cm (9.4) 1.19 0.06
Diastolic blood pressure, mmHg (11.2) 1.16 0.02
Myocardial infarction 1.70 0.03
Smoking status† 1.31 0.04
Ejection fraction‡ 1.92 0.01
Subpopulation with LV measurements (n=590) Odds ratio* p
Age, years (4.9) 1.12 0.15
Male 0.87 0.56
Height, cm (9.4) 1.23 0.07
Myocardial infarction 2.04 0.02
Smoking status† 1.38 0.03
Ejection fraction‡ 2.10 0.047
Left ventricular (LV) mass index, g/m² (20.9) 1.14 0.08
LV fractional shortening, % (8.0) 0.85 0.047
(1.16-3.18)
(0.96-1.31)
(1.11-3.77)
(1.03-1.87)
(0.55-1.38)
(95% CI)
(95% CI)
(0.98-1.25)
(0.76-1.62)
(1.07-2.70)
(0.73-1.00)
(1.00-1.44)
(1.02-1.31)
(1.02-1.68)
(1.01-4.39)
(0.98-1.34)
(0.98-1.53)
0.5 1 2 4
Figure 2. Multivariable adjusted predictors of 5-year change in premature ventricular contraction (PVC) frequency. Multivariable models
including all covariates listed for each population (please see the Methods section for selection of covariates). *The odds ratio for a 1-quintile
increase in 5-year change in PVCs per hour, per increase of SD of each continuous covariate or the presence (vs absence) of each categorical
variable. †Dichotomized into ever smokers vs never smokers. ‡Dichotomized into abnormal and borderline ejection fraction vs normal
ejection fraction.
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mechanisms, including via reducing blood pressure (although
this relationship was independent of blood pressures ascer-
tained as part of the study)32 or through more generalized
effects such as reducing general inflammation33 or reducing
weight.10,34 It is also possible that those with more PVCs did
not tolerate more physical exertion precisely because of their
frequent PVCs, and hence in this cross-sectional aspect of the
study we once again must acknowledge the possibility of
reverse causation.
Consistent with previous data,18,19 taller individuals exhibited
a greater PVC frequency, both before and after multivariable
adjustment (including adjustment for sex). Although height
displayed a trend toward greater PVC over time, this did not
reach statistical significance, suggesting that this more fixed
quality may be associated with a certain increase in PVCs that
then remains stable over time. Taller height has similarly been
shown to predict premature atrial contractions35 and atrial
fibrillation,36 suggesting that taller stature may reflect a general
propensity to arrhythmias rather than some pathophysiology
specific to ectopy arising from the ventricles alone.
In addressing this common arrhythmia recently shown to
predict important cardiovascular outcomes and mortality,4 the
current study has several strengths. First, we employed 24-hour
Holter monitoring, considered the gold standard in quantifying
PVCs, in a community-based population. To our knowledge, this
is the only community-based cohort in the United States with
such published Holter data and the only community-based
study in the world with published serial Holter measurements.
The CHS also employed particularly meticulous ascertainment
of the covariates considered for inclusion in our models. Finally,
to our knowledge, this is the first community-based study to
include echocardiographic measurements in considering pre-
dictors of PVCs. Indeed, ejection fraction, LV mass index, and
LV fractional shortening each proved to be significantly
associated with ventricular ectopy.
Several limitations of our study should be acknowledged.
As the study involved only those 65 years of age and older,
and the population was predominantly white, extrapolation of
our findings to younger individuals and to nonwhites should
be done with caution. The observational nature of our study
does not allow any conclusions about causality between the
parameters observed and PVC frequency. We were also
unable to comment on the relationship between acute
exposures (such as alcohol or smoking) and immediate
effects on PVCs. The results of the present study are
attributed to baseline measurements, and therefore we are
unable to comment on how the change in several exposures
influences the change in PVC frequency. There was likely
substantial mediation between the covariates included in the
multivariable models (eg, smoking and a higher blood
pressure increase the risk for a reduced ejection fraction
and MI), so that we may have underestimated the strength of
Table 4. Unadjusted Predictors of 5-Year Change in PVC
Frequency
Characteristic, Unit (SD)
Odds
Ratio* (95% CI) P Value
Immutable
Age, y, (4.9) 1.10 (0.97–1.26) 0.15
Male 1.73 (1.35–2.22) <0.0001
White race (vs nonwhite) 1.41 (0.82–2.42) 0.21
Height, cm (9.4) 1.32 (1.17–1.51) <0.0001
Potentially modifiable
Educational level, y (4.5) 0.98 (0.87–1.11) 0.71
Weight, kg (13.3) 1.26 (1.09–1.42) 0.001
Body mass index, kg/m2 (4.2) 1.09 (0.96–1.23) 0.17
Waist-to-hip ratio (0.10) 1.23 (1.09–1.38) 0.001
Heart rate, beats
per minute (10.9)
1.06 (0.94–1.20) 0.39
Hypertension 1.24 (0.98–1.58) 0.08
Diabetes mellitus 1.14 (0.80–1.61) 0.47
Coronary heart disease 1.59 1.15–2.18) 0.005
Congestive heart failure 1.89 (0.76–4.72) 0.17
Myocardial infarction 2.19 (1.41–3.43) 0.001
Atrial fibrillation 1.42 (0.62–3.25) 0.41
Ejection fraction below normal† 2.36 (1.44–3.85) 0.001
Left ventricular
mass index, g/m² (20.9)‡
0.79 (0.68–0.92) 0.003
Left ventricular
fractional shortening, % (8.0)‡
1.22 (1.03–1.41) 0.02
Directly modifiable
Systolic blood
pressure, mm Hg (21.5)
1.02 (0.90–1.16) 0.72
Diastolic blood
pressure, mm Hg (11.2)
1.16 (1.02–1.29) 0.02
Leisure-time physical activity§ 0.98 (0.87–1.11) 0.69
Exercise intensityk 1.04 (0.82–1.33) 0.73
ACE inhibitors 0.85 (0.49–1.46) 0.55
b-Blockers 0.88 (0.62–1.25) 0.47
Calcium channel blockers 0.97 (0.65–1.45) 0.89
Alcohol consumption,
units/week (10.8)
1.14 (0.91–1.41) 0.17
Smoking status¶ 1.40 (1.10–1.78) 0.007
ACE indicates angiotensin-converting enzyme; CI, confidence interval; PVC, premature
ventricular contractions.
*The odds ratio for a one-quintile increase in 5-year change in premature ventricular
contractions (PVC) per hour, per standard deviation (SD) increase in each continuous
covariate or the presence (vs absence) for each categorical variable.
†Dichotomized into abnormal and borderline ejection fraction vs normal ejection fraction;
‡Available for 952 participants.
§Odds ratio for a 1-quintile increase in 5-year change in PVCs per hour, per each doubling
in leisure-time physical activity.
kDichotomized into high- and intermediate-intensity exercisers vs low-intensity and no
exercisers.
¶Dichotomized into ever smokers vs never smokers.
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some associations. Finally, as with any observational study,
we cannot exclude either residual confounding or additional
confounding by unmeasured (or unknown) factors.
In conclusion, several common and potentially modifiable
risk factors, including a higher systolic blood pressure, less
physical activity, and smoking, were each associated with a
greater baseline PVC frequency, while a higher diastolic blood
pressure and smoking predicted an increased PVC frequency
over time. Therefore, optimizing blood pressure, increasing
physical activity, and smoking cessation may all represent
useful strategies in reducing PVC frequency and potentially
avoiding the harms of PVC-induced adverse outcomes.
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SUPPLEMENTAL MATERIAL 
 
Table S1. Median (interquartile range) of PVC frequency according to status of 5-year beta-
blocker usage among individuals using/not using beta-blockers at baseline. 
 
 
Using beta-blockers at baseline (n=117) 
  
Continued beta-
blockers (n=82) 
Beta-blockers 
discontinued (n=35) p   
PVCs per hour at baseline 1.0 (0.1 to 7.6) 0.9 (0.1 to 15.6) 0.95 
PVCs per hour in five years 0.8 (0.1 to 8.5) 4.6 (0.1 to 45.5) 0.09 
        
Not using beta-blockers at baseline (n=728) 
  Continued 
without beta-
blockers (n=691) 
Beta-blockers started 
(n=37) p   
PVCs per hour at the baseline 0.4 (01 to 4.4) 0.5 (0.1 to 5.6) 1.00 
PVCs per hour in five years 1.3 (0.1 to 12.0) 1.0 (0.1 to 20.6)  0.74 
p values are based on Mann-Whitney U test 
 
 
Ordinal regression analyses regarding changing beta-blocker use and change in 
PVC frequency among individuals using (n=117)/ not using (n=691) beta-
blockers at baseline. 
Using beta-blockers at baseline 
  Odds ratio 95% CI p 
unadjusted risk of cessation vs. continuing beta-
blockers 
1.79 0.87 to 3.68 0.11 
sex and age adjusted risk of cessation vs. 
continuing beta-blockers 
1.8 0.87 to 3.70 0.11 
Not using beta-blockers at baseline 
unadjusted risk of commencement vs. never use 
of beta-blockers 
1.18 0.66 to 2.13 0.57 
age and sex adjusted risk of commencement vs. 
never use of beta-blockers 
1.22 0.67 to 2.20 0.51 
The odds ratio for a one-quintile increase in 5-year change in PVCs per hour. All analyses additionally 
adjusted for baseline PVC frequency 
 
